Johnson & Johnson JNJ NYSE

Johnson & Johnson (JNJ) has shown moderate revenue growth over the past 3 years, expanding from $80.0B to $94.2B (average +5.6%/yr). Net income reached $26.8B, reflecting exceptional earnings expansion at +42.2%/yr on average. The net profit margin is 28.5%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 72.8% (high), with a +3.5pp trend over the period. With a $579B market cap and MOAT composite score of 100/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (83/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 53-year history, the company was profitable in 53 of 53 years — a perfect long-term track record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (100/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 73/100 with 4/7 criteria passed.